Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in New York Health Care Facilities, 1988

19Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

The emergence in 1988 of ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus (MRSA) in New York City was studied in nine hospitals and eight nursing homes. Of the 43 hospitalized patients studied, 21 were admitted from home, while nine of the 12 nursing home patients were transferred form a hospital. Twenty-four of the 55 patients had been treated previously with ciprofloxacin, and 26 had an identifiable risk factor for a nosocomial infection. MRSA was a contributing factor in at least five of the 21 deaths. MRSA resistance to ciprofloxacin was detected within three months of the drug's commercial availability, apparently emerged independently at a number of the health care facilities, and has become widespread. If such resistance is found in a health care facility, ciprofloxacin may not be useful as a first line antibiotic.

Cite

CITATION STYLE

APA

Budnick, L. D., & Schaefler, S. (1990). Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in New York Health Care Facilities, 1988. American Journal of Public Health, 80(7), 810–813. https://doi.org/10.2105/AJPH.80.7.810

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free